PETALING JAYA, MALAYSIA - Media OutReach Newswire - 3 November 2025 - TMC Life Sciences Berhad (TMCLS) remains on track for continued growth in FY2026, following a resilient FY2025 performance anchored by a commitment to clinical excellence, renewed engagement with insurance and corporate partners, strengthened marketing and branding initiatives, cost optimisation, and growing medical tourism interest.